References
- RoilidesESiglerLBibashiEKatsifaHFlarisNPanteliadisCDisseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this diseaseJ Clin Microbiol199937118259854057
- AnsteadGMSuttonDAGraybillJRAdiaspiromycosis causing respiratory failure and a review of human infections due to Emmonsia and Chrysosporium sppJ Clin Microbiol20125041346135422259200
- WagonerMDBadrIAHidayatAAChrysosporium parvum keratomycosisCornea199918561662010487440
- ShekharHGogiaVVashishtNEndogenous endophthalmitis by Chrysosporium: an opportunistic pathogenOcul Immunol Inflamm201422215816024564480
- NeohCFLeungLChanEThe Absorption and Clearance of Voriconazole 1% eye drops–an open label studyAntimicrob Agents Chemother2016 pii: AAC.00683-16
- FlorCruzVEvansJRMedical interventions for fungal keratitisCochrane Database Syst Rev20154CD004241
- PrajnaNVKrishnanTMascarenhasJThe mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazoleJAMA Ophthalmol2013131442242923710492
- ChengSCLinYYKuoCNLaiLJCladosporium keratitis–a case report and literature reviewBMC Ophthalmol20151510626286482
- ShobanaCSMythiliAHomaMIn vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugsJ Mycol Méd2015251444925541256